By BioSpace
Publication Date: 2026-01-16 07:54:00
NEWARK, Del.–(BUSINESS WIRE)–#Bioanalysis–QPS Holdings, LLC (QPS), an award-winning contract research organization (CRO) focused on bioanalysis and clinical trials, announces the successful implementation of Oracle Argus, a best-in-class pharmacovigilance system to support comprehensive safety case management for clinical trials.
The launch of the Oracle Argus drug safety platform underscores QPS’s commitment to improving patient safety, regulatory compliance and operational excellence in its customers’ clinical drug development programs. The integration of this industry-standard security platform strengthens QPS’s ability to capture, manage and report adverse events in accordance with global regulatory requirements.
“Ensuring patient safety and data integrity is at the heart of our work conducting clinical trials,” said Derek Grimes, Executive Vice President of QPS. “Oracle Argus provides us with a robust, scalable solution…
